Vault-13

Euclidean Capital LLC

NEW YORK, NY · CIK 1825034 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$439.8m reported value +12.1% vs Q1 2026
11positions
100.0%in top 10
1 new 0 added 0 reduced 0 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VANGUARD INTL EQUITY INDEX F ALLWRLD EX US VEU VEU 3,243,484 $271.6m61.76% 61.76% UnchangedShares held: Q3 2025 2.6m, Q4 2025 3.0m, Q1 2026 3.2m, Q2 2026 3.2m
2 VANGUARD INDEX FDS VALUE ETF VTV VTV 520,000 $113.3m25.76% 25.76% UnchangedShares held: Q3 2025 0, Q4 2025 520.0k, Q1 2026 520.0k, Q2 2026 520.0k
3 ISHARES TR MSCI INDIA ETF INDA INDA 369,600 $18.3m4.15% 4.15% UnchangedShares held: Q3 2025 369.6k, Q4 2025 369.6k, Q1 2026 369.6k, Q2 2026 369.6k
4 ORIC PHARMACEUTICALS INC COM ORIC ORIC 989,410 $10.7m2.44% 2.44% UnchangedShares held: Q3 2025 989.4k, Q4 2025 989.4k, Q1 2026 989.4k, Q2 2026 989.4k
5 TEAMSHARES INC COM TMS TMS 1,099,974 $9.0m2.06% 2.06% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
6 FOGHORN THERAPEUTICS INC COM FHTX FHTX 1,573,761 $7.7m1.75% 1.75% UnchangedShares held: Q3 2025 1.6m, Q4 2025 1.6m, Q1 2026 1.6m, Q2 2026 1.6m
7 PMV PHARMACEUTICALS INC COM PMVP PMVP 2,627,643 $3.5m0.80% 0.80% UnchangedShares held: Q3 2025 2.6m, Q4 2025 2.6m, Q1 2026 2.6m, Q2 2026 2.6m
8 ALECTOR INC COM ALEC ALEC 1,307,858 $2.6m0.60% 0.60% UnchangedShares held: Q3 2025 1.3m, Q4 2025 1.3m, Q1 2026 1.3m, Q2 2026 1.3m
9 SURROZEN INC COM NEW SRZN SRZN 87,696 $2.3m0.52% 0.52% UnchangedShares held: Q3 2025 87.7k, Q4 2025 87.7k, Q1 2026 87.7k, Q2 2026 87.7k
10 TENAYA THERAPEUTICS INC COM TNYA TNYA 1,015,705 $750.7k0.17% 0.17% UnchangedShares held: Q3 2025 1.0m, Q4 2025 1.0m, Q1 2026 1.0m, Q2 2026 1.0m
11 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 170,833 $2.8k0.00% 0.00% UnchangedShares held: Q3 2025 170.8k, Q4 2025 170.8k, Q1 2026 170.8k, Q2 2026 170.8k